vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and SuperCom Ltd (SPCB). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $14.2M, roughly 1.9× SuperCom Ltd). SuperCom Ltd runs the higher net margin — 37.5% vs -10.3%, a 47.8% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs -1.5%). NeuroPace Inc produced more free cash flow last quarter ($409.0K vs $-3.6M).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.

NPCE vs SPCB — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.9× larger
NPCE
$26.6M
$14.2M
SPCB
Growing faster (revenue YoY)
NPCE
NPCE
+25.3% gap
NPCE
23.9%
-1.5%
SPCB
Higher net margin
SPCB
SPCB
47.8% more per $
SPCB
37.5%
-10.3%
NPCE
More free cash flow
NPCE
NPCE
$4.0M more FCF
NPCE
$409.0K
$-3.6M
SPCB

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
NPCE
NPCE
SPCB
SPCB
Revenue
$26.6M
$14.2M
Net Profit
$-2.7M
$5.3M
Gross Margin
77.4%
61.2%
Operating Margin
-6.6%
16.3%
Net Margin
-10.3%
37.5%
Revenue YoY
23.9%
-1.5%
Net Profit YoY
48.0%
79.5%
EPS (diluted)
$-0.08
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
SPCB
SPCB
Q4 25
$26.6M
Q3 25
$27.4M
Q2 25
$23.5M
$14.2M
Q1 25
$22.5M
Q4 24
$21.5M
Q3 24
$21.1M
Q2 24
$19.3M
$14.4M
Q1 24
$18.1M
Net Profit
NPCE
NPCE
SPCB
SPCB
Q4 25
$-2.7M
Q3 25
$-3.5M
Q2 25
$-8.7M
$5.3M
Q1 25
$-6.6M
Q4 24
$-5.3M
Q3 24
$-5.5M
Q2 24
$-7.5M
$3.0M
Q1 24
$-8.9M
Gross Margin
NPCE
NPCE
SPCB
SPCB
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
61.2%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
52.3%
Q1 24
73.6%
Operating Margin
NPCE
NPCE
SPCB
SPCB
Q4 25
-6.6%
Q3 25
-9.5%
Q2 25
-29.0%
16.3%
Q1 25
-22.9%
Q4 24
-17.0%
Q3 24
-20.1%
Q2 24
-32.4%
7.7%
Q1 24
-41.6%
Net Margin
NPCE
NPCE
SPCB
SPCB
Q4 25
-10.3%
Q3 25
-12.8%
Q2 25
-36.8%
37.5%
Q1 25
-29.3%
Q4 24
-24.5%
Q3 24
-25.9%
Q2 24
-39.0%
20.6%
Q1 24
-49.2%
EPS (diluted)
NPCE
NPCE
SPCB
SPCB
Q4 25
$-0.08
Q3 25
$-0.11
Q2 25
$-0.26
$1.32
Q1 25
$-0.21
Q4 24
$-0.16
Q3 24
$-0.19
Q2 24
$-0.26
$1.19
Q1 24
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
SPCB
SPCB
Cash + ST InvestmentsLiquidity on hand
$61.1M
$15.0M
Total DebtLower is stronger
$23.6M
Stockholders' EquityBook value
$19.0M
$37.3M
Total Assets
$105.6M
$65.5M
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
SPCB
SPCB
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
$15.0M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
$5.7M
Q1 24
$58.9M
Total Debt
NPCE
NPCE
SPCB
SPCB
Q4 25
Q3 25
Q2 25
$23.6M
Q1 25
Q4 24
Q3 24
Q2 24
$29.2M
Q1 24
Stockholders' Equity
NPCE
NPCE
SPCB
SPCB
Q4 25
$19.0M
Q3 25
$18.5M
Q2 25
$19.4M
$37.3M
Q1 25
$24.3M
Q4 24
$8.0M
Q3 24
$9.8M
Q2 24
$9.9M
$13.8M
Q1 24
$14.3M
Total Assets
NPCE
NPCE
SPCB
SPCB
Q4 25
$105.6M
Q3 25
$107.3M
Q2 25
$106.1M
$65.5M
Q1 25
$110.2M
Q4 24
$94.6M
Q3 24
$96.3M
Q2 24
$94.4M
$49.6M
Q1 24
$98.9M
Debt / Equity
NPCE
NPCE
SPCB
SPCB
Q4 25
Q3 25
Q2 25
0.63×
Q1 25
Q4 24
Q3 24
Q2 24
2.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
SPCB
SPCB
Operating Cash FlowLast quarter
$506.0K
$-2.2M
Free Cash FlowOCF − Capex
$409.0K
$-3.6M
FCF MarginFCF / Revenue
1.5%
-25.3%
Capex IntensityCapex / Revenue
0.4%
10.0%
Cash ConversionOCF / Net Profit
-0.41×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$-14.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
SPCB
SPCB
Q4 25
$506.0K
Q3 25
$-1.9M
Q2 25
$-2.1M
$-2.2M
Q1 25
$-7.5M
Q4 24
$-4.8M
Q3 24
$-1.7M
Q2 24
$-3.9M
$-950.0K
Q1 24
$-7.5M
Free Cash Flow
NPCE
NPCE
SPCB
SPCB
Q4 25
$409.0K
Q3 25
$-2.0M
Q2 25
$-2.3M
$-3.6M
Q1 25
$-7.5M
Q4 24
$-4.8M
Q3 24
$-1.8M
Q2 24
$-4.0M
$-1.6M
Q1 24
$-7.6M
FCF Margin
NPCE
NPCE
SPCB
SPCB
Q4 25
1.5%
Q3 25
-7.2%
Q2 25
-9.6%
-25.3%
Q1 25
-33.4%
Q4 24
-22.5%
Q3 24
-8.7%
Q2 24
-20.6%
-10.8%
Q1 24
-42.1%
Capex Intensity
NPCE
NPCE
SPCB
SPCB
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.7%
10.0%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.5%
Q2 24
0.3%
4.2%
Q1 24
0.6%
Cash Conversion
NPCE
NPCE
SPCB
SPCB
Q4 25
Q3 25
Q2 25
-0.41×
Q1 25
Q4 24
Q3 24
Q2 24
-0.32×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons